Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · IEX Real-Time Price · USD
3.100
-0.180 (-5.49%)
At close: Jul 2, 2024, 4:00 PM
3.170
+0.070 (2.26%)
After-hours: Jul 2, 2024, 4:58 PM EDT
Puma Biotechnology Market Cap
Puma Biotechnology has a market cap or net worth of $149.54 million as of July 2, 2024. Its market cap has decreased by -9.81% in one year.
Market Cap
149.54M
Enterprise Value
153.11M
1-Year Change
-9.81%
Ranking
Category
Stock Price
$3.10
Market Cap Chart
Since April 24, 2012, Puma Biotechnology's market cap has decreased from $280.60M to $149.54M, a decrease of -46.71%. That is a compound annual growth rate of -5.03%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 158.20M | -23.20% |
Dec 29, 2023 | 206.00M | 6.68% |
Dec 30, 2022 | 193.10M | 55.35% |
Dec 31, 2021 | 124.30M | -69.53% |
Dec 31, 2020 | 408.00M | 19.68% |
Dec 31, 2019 | 340.90M | -56.07% |
Dec 31, 2018 | 776.00M | -79.08% |
Dec 29, 2017 | 3.71B | 228.21% |
Dec 30, 2016 | 1.13B | -55.55% |
Dec 31, 2015 | 2.54B | -55.43% |
Dec 31, 2014 | 5.71B | 92.11% |
Dec 31, 2013 | 2.97B | 452.60% |
Dec 31, 2012 | 537.50M | 91.55% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Achieve Life Sciences | 164.15M |
Ventyx Biosciences | 159.33M |
OrganiGram Holdings | 159.19M |
Biomea Fusion | 158.88M |
TruBridge | 158.63M |
Compugen | 156.68M |
Vaxart | 156.60M |
Elevation Oncology | 156.27M |